Sterile injectable drug manufacturing facility with aseptic processing equipment
Injectable Manufacturing

Injectable Drug Sterilization: Key Challenges and Strategies

Lifecore Injectables CDMO
Injectable Manufacturing

Expert insights on terminal sterilization, sterile filtration, aseptic processing and Annex 1 compliance.

Nathan Meehan, Process Engineer at Lifecore Injectables CDMO, highlights sterilization strategies in injectable manufacturing, including challenges, changing regulatory expectations and isolator technology.

Nathan Meehan, Process Engineer at Lifecore Injectables CDMO, highlights sterilization strategies in injectable manufacturing, including challenges, changing regulatory expectations and isolator technology.

Choosing a Sterilization Strategy

Terminal sterilization, sterile filtration and aseptic processing each suit different products depending on heat sensitivity, viscosity and container type.

Evolving Regulatory Expectations

Annex 1 places greater emphasis on contamination control strategy, risk management and barrier technologies.

Future Trends

Isolators, closed systems and automation are reducing human intervention and improving sterility assurance.

Download This White Paper

Biotechnology Media Insights

Continue to Biotechnology Media Insights to access this white paper.

Pharmaceutical & Biotechnology White Papers | Biotechnology Media Insights